There’s a rhythm to this one. MedaSync and Omega Healthcare Investors just linked up, and the beat they’re laying down could change how skilled nursing facilities think about revenue. Not the usual hype track either, this is about making sure care gets paid for, correctly and consistently, in one of the most complicated reimbursement arenas in American healthcare.
MedaSync isn’t some generic revenue cycle tool draped in AI stickers. It’s a platform designed specifically for skilled nursing facilities, those operators living on the edge of constant regulatory change. Medicare PDPM, Medicaid case-mix indexes, Quality Incentive Programs, Medicare Advantage, the alphabet soup that keeps administrators up at night. One wrong code, one missed documentation detail, and money evaporates. MedaSync’s software reads between the lines, curates intelligent patient summaries, and catches misalignments before they become lost dollars. Think less paperwork panic, more financial clarity.
The story started in Cleveland back in 2016, when Ryan Edgerly teamed up with Gene Groys. Groys had already built OnShift, so he knew where the inefficiencies lived. Edgerly had watched from the inside how reimbursement chaos was crushing operators. They didn’t just decide to chase a market, they decided to fix a mess that had been ignored for too long. And the proof is here: customer acquisition more than doubling year over year, revenues climbing, hundreds of skilled nursing organizations nationwide trusting the product. For a team barely breaking double digits in headcount, that’s called punching above weight.
Omega Healthcare Investors saw it too. They didn’t disclose the size of their strategic investment, but the signal is loud enough. This is a $7B REIT betting on the infrastructure that keeps its portfolio operating. Adding Megan Krull, their Senior VP of Operations, to MedaSync’s board wasn’t window dressing, it was strategy. It ties capital directly to the execution layer, accelerating adoption in facilities that can’t afford to wait.
So here’s the larger business lesson: specialized beats generic, every time. MedaSync isn’t trying to be everything for everyone. It’s a surgical tool in a field where blunt instruments used to pass as solutions. And when specialized intelligence meets the right financial partner, the sector moves. For skilled nursing, the takeaway is simple, real-time insight is no longer optional, it’s survival.
